Open AccessA patient with advanced lung squamous cell carcinoma who failed to benefit from albumin bound paclitaxel plus pembrolizumab achieved partial response with second-line treatment of docetaxel plus pembrolizumab: a case report
Author(s) -
Fan Zhang,
Yu Xu,
Shenghu Guo,
Suping Li,
Ke Ma,
Junyan Wang,
Suju Wei
Publication year - 2022
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-22-960
Subject(s) - medicine , pembrolizumab , docetaxel , carboplatin , lung cancer , oncology , chemotherapy , pemetrexed , squamous cell carcinoma of the lung , chemotherapy regimen , lung , regimen , cancer , gastroenterology , immunotherapy , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom